SlideShare a Scribd company logo
1 of 108
 Carbohydrates are the largest source of dietary
calories.
 The major carbohydrates are starch, lactose and
sucrose
 The main carbohydrates in body metabolism is
glucose
 transported to muscle (and other tissues) via blood
 stored in liver and muscle as glycogen
 ATP produced more quickly from CHO than from fats
or proteins
 CHO stores can be depleted
Carbohydrates (Fuels)
Digestion
 Starch digestion begins in mouth by the
salivary α-amylase which converts starch to
smaller polysaccharides called α-dextrins
 Pancreatic α-amylase continue the digestion of
α-dextrins into maltose, maltotriose &
oligosaccharides called limited dextrins
 Digestion of maltose, maltotriose, sucrose &
lactose continues by disaccharidases attached
to the membrane of surface of the brush
border (microvilli)of intestinal epithelial cells
 The monosaccharides produced are
transported into the intestinal cells
Sucrase-isomaltase complex
 Similar to glucosamylase attached to membrane
with two polypeptides. Protrudes into the
intestinal lumen, an intestinal protease clips in
into two separate subunits that remain
attached to each other. Each subunit site has a
catalytic site that differs in substrate specificity.
The sucrase-maltase site accounts for 100% of
intestinal ability to hydrolyze sucrose in addition
to maltase activity. The isomaltase-maltase site
accounts for almost all activity to hydrolyze α 1-
6 bonds in addition to maltase activity.
Trehalase & Lactase
 Trehalase: One catalytic site & hydrolyzes
the glycosidic bond in trehalose
(disaccharide of two glucosyl units
attached by their anomeric carbons.
 Lactase - Glucosyl cermidase Complex:
Glycoprotein found in the brush border
that has two caralytic sites extending in
the intestinal lumin. It hydrolyzes lactose
and the B-bonds between glucose or
galactose and ceramide in glycolipids.
Dietary Fiber
 Composed principally of polysaccharides which
can not be digested by human enzymes of
intestinal tract
 Derivatives of lignan ( cellulose, hemicellulose,
lignin, pectin s, mucilages & gums)
 Bacterial flora of the colon metabolize the
fibers to gases(H2,CO2,CH4) & short chain fatty
acids
 Fatty acids are absorbed by colonic cells
 Fibers is seen to soften the stool, thereby
reducing pressure on colonic wall & enhancing
expulsion of feces
Glucose Absorption
 Two types of glucose transport
proteins are present in the intestinal
cells
– Na+ dependent: an active transport which
depends on cotransport of sodium and
glucose
– Facilitated : passive transport known as
Glut 1 -4
 Cell membranes are not inherently permeable to
glucose. There are many glucose transporters.
 GLUT- 1 enables basal non- insulin stimulated
glucose uptake (erythrocytes)
 GLUT- 2 transport glucose into beta cells, a pre-
requisite for glucose sensing.
 GLUT- 3 enables non- insulin mediated glucose
uptake into brain.
 GLUT- 4 enables much of the peripheral action of
insulin (muscles, adipose)
Glucose transporters
Absorption of carbohydrates
 Sugars are transported
across the intestinal
epithelial cells into the
blood
 Not all complex sugars
are digested in the
same rate within the
intestine
 Glycemic index of the
food is an indication of
how rapidly blood
glucose level rises after
consumption
Whole weat 100
pasta 67
cornflakes 121
potatoes 120
Ice cream 69
fruits 52
The waiting room
 Deria Voider is a 20 year old exchange student
from Nigeria who has noted gastrointestinal
bloating, abdominal cramps, and intermittent
diarrhea ever since arriving in the united states
6 months earlier. A careful history shows that
these symptoms occur most commonly about
45 minutes to 1 hour after eating breakfast but
may occur after other meals as well. Dairy
products, not a part of Deria’s diet in Nigeria,
were identified as the probable offending agent
because her gastrointestinal symptoms
disappeared when milk & milk products were
eliminated from here diet.
The waiting room
 Lactose intolerance can either be the result
of a primary deficiency of lactase production
in the small bowel or it can be secondary to
an injury to the intestinal mucosa, where
lactase is normally produced.
 The lactose that is not absorbed is
converted by colonic bacteria to lactic acid .
Methane gas and H2 gas
 The osmotic effect of lactose & lactic acid in
the bowel lumen is responsible for the
diarrhea seen often
 A 15 year old complained of abdominal discomfort, a
feeling of bloated, increase passage of urine, more
recently, the development of diarrhea. His only change
in diet noted at the time was the introduction of yogurt
into his diet. He was consuming 1-2 large cartons per
day. A lactose test was performed, whereby the young
man was given 50 g lactose in an aqueous vehicle to
drink. Plasma glucose levels did not rise by more than
1 mmol/ l ( 18g /dl) over the next 2 hour, with
sampling at 30 minutes interval. A diagnosis of lactose
intolerance was made.
 Comment: This is due to deficiency of lactase. Lactase
activity decreases with age in children but this decline
is genetically predetermined. A diagnosis is made by
challenging the small bowel with lactose and
monitoring the rise in plasma glucose. An increase of
more than 1.7 mmol/l (30 g/dl) is considered normal.
Lactose intolerance
Glycogen Metabolism
Glycogenolysis
 Occurs mainly in liver & muscles
 Both pathways in the liver & muscle
are the same
 End product in liver is glucose, while in
muscle is glucose 6 phosphate
Regulation of Glycogen Metabolism in Liver
 When blood glucose level increases immediately after
a meal, insulin level increases, whole glycogen level
decreases.
 Increase in insulin/glycogen ration inhibits
glycogenolysis & stimulates glycogenesis.
 The immediate removal of blood glucose helps bring
circulating blood glucose levels back to normal 80-100
mg/dl range.
 Postprandilly, insulin levels decrease & glucagon levels
increase.
 The fall of the insulin/glycogen ratios results in
inhibition of glycogenesis and increased
glycogenolysis.
 Substantial proportion of liver glycogen is degraded
within the few first hours after eating.
Regulation of Glycogenolysis &
Glycogenesis in Skeletal Muscle
 Skeletal muscle glycogen is degraded only when
the demand for ATP generation is high.
 Regulation of glycogen metabolism differs from
that in liver.
1. Glucagon has no effect (muscle glycogen do not
vary with fasting/feeding state)
2. AMP is an alosteric activator of muscle glycogen
phosphorylase but not liver isozyme.
3. Glucose is not a physiological inhibitor of
glycogen phosphorylase.
4. Epinephrine effects are similar to that in liver.
Epinephrine & Ca2+ in the Regulation of Liver
Glycogen
 Epinephrine released from adrenal medulla in
response to neural signals reflecting an increased
demand for glucose.
 Epinephrine stimulated glycogenolysis in liver
through two different receptors.
– B-Receptors: transmit a signal through G-
protein to adenylate cyclase, which increases
cAMP.
– Α-Receptors: increases CA2+ levels in the liver,
which is mediated by the phosphatidylinositol
bisphosphate - CA2+ signal transduction
system.
Function of glycogen in Skeletal Muscle & Liver
 It functions as a reservoir of glucosyl units for ATP
generation.
 Glycogen is usually degraded to glucose-1-
phosphate which is converted into glucose-6-
phosphate.
 In skeletal muscles and other cell types, glucose-6-
phosphate is used by the cell to produce ATP
(Absence of glucose-6-phosphatase).
 In liver, glycogen serves a very different purpose.
Liver glycogen is the first and immediate source of
glucose for the maintenance of blood glucose
level. In liver, glucose-6-phosphate is converted to
free glucose by G-6-phosphatase, present only
liver and kidneys.
Futile Cycles
 Regulation of glycogen synthesis serves to
prevent futile cycling and waste of ATP.
 Futile cycle refers to a situation in which a
substrate is converted to a product through one
pathway & the product converted back to the
substrate through another pathway.
 Because biosynthesis pathway is energy
requiring, futile cycling results in a waste of high
energy phosphate bonds.
 Therefore, glycogenesis is activated when
glycogenolysis is inhibited and vice versa.
The Waiting Room (1)
A newborn baby girl, Getta Garbo, was born
after a 38-week gestation. Her mother, a 36-
year-old woman, had moderate hypertension
during the last trimester of pregnancy related
to a recurrent urinary tract infection that
resulted in a severe loss of appetite and
recurrent vomiting in the month preceding
delivery. Fetal bradycardia (slower than normal
feta heart rate) was detected with each uterine
contraction of labor, a sign of possible fetal
distress. At birth Getta was cyanotic (a bluish
discoloration caused by lack of adequate
oxygenation of tissues) and limp. She
responded to several minutes of assisted
ventilation.
The Waiting Room (2)
Physical examination in the nursery at 10 minutes,
showed a thin, malnourished female newborn. Her
body temperature was slightly low, her heart rate
was rapid and her respiratory rate of 35
breaths/minute was elevated. Getta’s birth weight
was only 2,100g (normal 3,300 g). Her length was
47 cm, and her head circumference was 33cm (low
normal). Getta’s serum glucose when she was
unresponsive was 14 mg/dL. (glucose below 40
mg/dL (2.5 mM) is abnormal in newborn). At 5
hours of age, she was apneic (not breathing) and
unresponsive. Ventilatory resuscitation was initiated
and a cannula placed in the umbilical vein. Blood
for a glucose level was drawn through this cannula,
and 5mL of a 20% glucose solution was injected.
Getta slowly responded to this therapy.
The Waiting Room (3)
Maternal blood glucose readily crosses the placenta to enter the
fetal circulation. During the last 9 or 10 weeks of gestation,
glycogen formed from maternal glucose is deposited in the fetal
liver under the influence of the insulin-dominated hormonal
milieu of that period. At birth, maternal glucose supplies cease,
causing a temporary physiologic drop in glucose levels in the
newborn’s blood even in normal healthy infants. This drop
serves as one of the signals for glucagon release from the
newborn’s pancreas, which, in turn stimulates glycogenolysis.
As a result, the glucose levels in the newborn return to normal.
Healthy full-term babies have adequate stores of liver glycogen
to survive short (12 hours) periods of caloric deprivation
provided other aspects of fuel metabolism are normal. Because
Getta Garbo’s mother was markedly anorexic during the critical
period when the fetal liver is normally synthesizing glycogen
from glucose supplied in the maternal blood, Getta’s liver
glycogen is the major source of fuel for the newborn in the
early hours of life, Getta became profoundly hypoglycemic
within 5 hours of birth because of her low levels of stored
carbohydrates.
electron
transport
chain
Aerobic Metabolism
Oxidation Phosphorylation
Kreb’s
cycle
Glycolysis
(carbohydrates)
(proteins)
Beta Oxidation
(fats)
NADH
FADH2
O2 H2O
ADP + Pi ATP
acetyl
CoA
mitochondria
oxidation
phosphorylation
Glycolysis
 uses only CHO
 occurs in sarcoplasm
 first step is glucose transport into tissues
 after entry, 2 ATP are used (with glucose)
 glucose (C6) is split into two C3 molecules
 final product is pyruvate
 4 ATP are synthesized
 pyruvate forms either lactate or enters
mitochondria
Glycolysis
Functions of Glycolysis
 ATP Production
 Synthesis of UDP-glucose, sialic
acid & mannosa
 Synthesis of serine & alanine
 Synthesis of TG from DHAP & fatty
acids
 In RBC, synthesis 2,3 DPG
glucose
ATP
ATP
PFK
4 ATP
pyruvate
lactate acetyl CoA
mitochondria
glycogenolysis
sarcolemma
blood
glycolysis
Overview of Glycolysis
Glycolysis
Lactate Production
 Major tissue sites of lactate production in a
resting man (g/day)
RBC 29
Skin 20
Brain 17
Skeletal muscles 16
Renal medulla 15
Intestinal mucosa 8
Other tissues 10
Total Production 115
Electron Transport Chain (ETC)
Oxidative Phosphorylation
Oxidation
 NADH and FADH2 transfer electrons to ETC
 final acceptor of electrons is O2
Phosphorylation
 energy generated by oxidation used to
resynthesize ATP
– 3 ATP from each NADH
– 2 ATP from each FADH2
1,3 DPG
2,3 DPG mutase
2,3 DPG
2,3 DPG phosphatase
2-PG
2,3 DPG synthesis & degradation
ADP
ATP
Regulation of Glycolysis
 Hexokinase inhibited by G-6-P with low km for
glucose
 PFk-1 is the rate limiting enzyme activated by
AMP and Fructose-2-6 bisphosphate (alosteric)
 PFK-1 inhibited by ATP & citrate.
 Pyruvate kinase present in brain and skeletal
muscles has no alosteric site & hence does not
contribute toward regulation of glycolysis in
these tissues.
 Liver pyruvate kinase is inhibited by
phosphorylation (CAMP) & alosterically inhibited
by ATP.
Dental Caries
 Ivan Applebod is a 56-year-old morbidly
obese accountant. He decided to see his
dentist because he felt excruciating pain in
his teeth when he ate ice-cream. He really
likes sweets and keeps hard candy in his
pocket. The dentist noted from Mr.
Applebod’s history that he had numerous
cavities as a child in his baby teeth. At this
visit, the dentist found cavities in two of
Mr. Applebod’s teeth.
Comment
 The dental caries in Ivan Applebod’s mouth were
case principally by the low ph generated from lactic
acid production by oral bacteria. Below a ph of 5.5
decalcification of tooth enamel & dentine occurs.
Lactobacilli and s. mutants are major contributors
to this process because almost all of their energy is
derived from the conversion of glucose or fructose
to lactic acid, and they are able to form well at low
ph generated by this process. The dentist explained
that bacteria in his dental plaque could convert all
the sugar in his candy into acid in less than 20
minutes. The acid is buffered by bicarbonate &
other buffers in saliva, by saliva production
decreases in the evening. Thus, the acid could
dissolve the hyroxyapptite in his tooth enamel
during the night.
 lactate formation
 enters mitochondria (i.e. Kreb’s cycle)
 formation of Kreb’s cycle intermediates
Pyruvate goes in one of three directions
Metabolic Fate of Pyruvate
TCA Cycle
 primary function is to reduce NAD+ and FAD
 acetyl CoA (C2) combines with a C4
molecule forming a C6 molecule
 C6 molecule is partially degraded back to a
C4 molecule
 each loss of C gives off a CO2
Kreb’s Cycle
(Citric Acid Cycle)
electron
transport
chain
Overview of Aerobic
Metabolism
Kreb’s
cycle
(proteins)
NADH
FADH2
O2 H2O
ADP + Pi ATP
acetyl
CoA
1. Preparation
for entry into
Kreb’s cycle
2. Removal of
“energized”
electrons
3. 1º ATP synthesis;
Oxidation-
phosphorylation
mitochondria
Beta Oxidation
(fats)
Glycolysis
(carbohydrates)
Gluconeogenesis
 Sites include liver & kidney while
substrates include, amino acids,
lactate, pyruvate, glycerol.
 Cori & alanine cycles for transport of
intermediates between site of
production of these metabolites and
site of synthesis.
 Many enzymes of glycolysis are
common to gluconeogenesis.
Gluconeogenesis(1)
 Irrversible enzymes of glycolysis are
replaced by gluconeogenesis
enzymes.
1. Pyruvate kinase – pyruvate
carboxylase & PEPCK
2. PFK ---- F 2,6 diphosphatase
3. Glucokinase --- Glu 6 phosphatase
Gluconeogenesis(2)
Gluconeogenesis - Bypass Enzymes
Glucose
oxaloacetate
Glucose-6-Phosphate
Fructose-6-Phosphate
Fructose 1,6 Bisphosphate
DHAP + Glyceraldehyde-3-P
Glyceraldehyde-3-P
Pyruvate
PEP
2-Phosphoglycerate
3-Phosphoglycerate
1,3-BPG
Gluconeogenesis - Bypass Enzymes
pyruvate + CO2 + ATP + H2O  oxaloacetate + ADP,Pi + 2H+
oxaloacetate + GTP  PEP + GDP + CO2
10. Pyruvate carboxylase & PEP carboxykinase
(+) acetylCoA & (-) ADP
3.Fructose 1,6-bisphosphatase
(-) fructose 2,6-bisphosphate (low fasting – high Fed)
(-) AMP
fructose 1,6 bisphosphate + H2O  fructose 6-phosphate + Pi
1. Glucose 6-phosphatase
glucose 6-phosphate + H2O  glucose + Pi
GLUCONEOGENESIS
Liver
2Pyruvate + 4ATP + 2NADH
2GTP
Glucose + 4ADP + 2NAD+
2GDP
to blood
 Galactose metabolism occurs in liver.
 Galactose UDP-galactose
GK
Uridyl transferase
UDP- glucose
Galactose metabolism
 Occurs in liver & adipose tissue
 Fructose Fructose 6 phos
fructokinase
Glucose 6 phos
Fructose metabolism
 The plasma glucose concentration reflects the
balance between intake, tissue utilization &
endogeneous production .
 Insulin promotes up take of glucose thus decreasing
plasma glucose while glucagon stimulates both the
release of glucose from glycogen stores & its denovo
synthesis, thus causing an increase in plasma
glucose.
 Glucose stimulates the secretion of insulin &
suppresses the secretion of glucagon.
Glucose Homeostasis
 Insulin acts on three main targets, liver, adipose &
muscles.
 In liver insulin stimulates, glycolysis, glycogenesis &
lipogenesis & suppresses lipolysis.
 In peripheral tissues, insulin induces lipoprotein
lipase activity & thus stimulates triglyceride synthesis.
 In muscles, insulin increases glucose & amino acid
transport & glycogen synthesis.
Metabolic effects of insulin
 Glucagon main effect is the mobilization of the fuel
reserves for the maintenance of the blood glucose
level between meals.
 Glucagon inhibits glucose- utilizing pathways and the
storage of metabolic fuels.
 It acts on liver, to stimulate glycogenolysis and inhibit
glycogenesis, glycolysis and lipogenesis.
 Gluconeogenesis and ketogenesis are then activated
 Epinephrine has effects similar to glucagon in the
liver but works through a different receptor. It
promotes an increase in blood glucose in response to
stress
Metabolic effects of Glucagon
 The glucose level in the vicinity of the B- cell is
sensed by the transporter GLUT- 2. Glucose is carried
into the cell, where it is phophorylated into G-6- P by
glucokinase which also is a part of the glucose
sensing mechanism. Increased G-6- P increases
glucose utilization and ATP production in the B- cell.
This changes the flux of ions across the cell
membrane, depolarizes the cell and increases the
concentration of Ca2+. Hence insulin is exocytosed.
 Insulin secretion is biphasic. The first phase occurs
over 10- 15 minutes of stimulation which release the
preformed insulin. The second phase, which lasts up
to 2 hours, is the release of newly synthesized
insulin.
Stimulation of insulin secretion by glucose
 Insulin secretion is also stimulated by gastrointestinal
hormones (insulinotropic peptide, cholecystokinin)
and amino acids, such as leucine, arginine, and
lysine. Thus, the insulin response to orally
administered glucose is greater than to an
intravenous infusion.
Stimulation of insulin secretion by glucose
 Hypoglycemia is defined as a blood glucose
concentration below 2.5 mmol/ L ( 45 mg/dl).
 Epinephrine and glucagon are released, resulting in a
stress response, the manifestation of which may
include sweating, trembling, increased heart rate and
feeling of hunger. If blood glucose continues to fall,
brain function is compromised (neuroglycopenia).
 Hypoglycemia in healthy individuals is usually mild
and may occur during exercise, after a period of
fasting or due to alcohol ingestion.
 Hypoglycemia may be caused by a rare insulin
secreting tumor of the beta- cells ( insulinoma) or
overdose of exogenous insulin.
Hypoglycemia
 A 12 year old diabetic boy was playing with his
friends. He received his normal insulin injection in the
morning but continued playing through the lunch
time without a meal. He became confused and
fainted. He was instantly given an injection of
glucagon from the emergency kit his father carried,
and recovered within minutes.
 Comment : An immediate improvement after
glucagon injection confirms this boy’s symptoms
were caused by hypoglycemia ,caused by the
exogenous insulin and insufficient food intake.
Spectacular recovery from hypoglycemia was due to
the action of glucagon. In hospital, hypoglycemic
patients who can not eat or drink are treated with an
intravenous infusion of glucose. An intramuscular
glucagon injection is an emergency measure that can
be applied at home.
Severe hypoglycemia is a medical emergency
 A middle aged man, emaciated, chronic alcoholic
collapsed and was transported to ER. Physical
examination revealed a somewhat clammy skin, unusual
for winter morning, rapid breathing and a rapid heart
rate. Laboratory tests indicate a blood sugar of 2.5
mmol/l ( 50g/dl), and a blood alcohol level of 0.2 %.
Subsequent tests indicated a normal level of CPK, high
serum level of AST, a slight acidic pH (7.29), low pCO2
and high blood lactate. The man responded to infusion of
a glucose solution & regained consciousness.
 Comment: This patient probably had not eaten breakfast
before starting his morning drinking. His glycogen stores
were negligible, so he was dependent on
gluconeogenesis for maintenance of blood glucose
concentration, but gluconeogenesis may be compromised
both by liver damage and by limited muscle mass
Alcohol Excess and Hypoglycemia-1
 Alcohol is metabolized primarily in the liver. Two steps
metabolism of alcohol is relatively unregulated, leading
to a rapid increase in hepatic NADH. This shifts the
equilibrium of LDH catalyzed reaction towards lactate
formation ( lacticacidemia). Also shifts cytosolic
oxaloacetate towards malate formation, reducing
gluconeogenesis from TCA. In addition DHAP is shifted
toward glycerol- 3- phosphate formation and thus
reducing gluconeogenesis from glycerol.
 The low blood glucose leads to a stress response 9
rapid heart beat, clammy skin), an effort to enhance
stimulation of gluconeogenesis combined action of
glucagon and epinephrine. Rapid breathing is
physiological response to metabolic acidosis.
Alcohol Excess and Hypoglycemia 2
 Premature babies are more susceptible to
hypoglycemia than normal babies because:
They have larger brain to body ratio.
 Small stores of glycogen.
 Limited capacity of live gluconeogenesis
because of immaturity of the liver cells
and the immaturity of PEPCK.
 Limited capacity for ketogenesis.
Sudden Infant Death Syndrome (SIDS)
 DM is a group of metabolic diseases characterized by
hyperglycemia leading to long term complication.
 It is common, which affects 1-2 % of populations.
 There are two main forms diabetes, 10 % have type
I and 90% have type 2.
 Type 1 patients are unable to produce insulin and
must receive exogenous insulin to survive.
 Type 2 patients have at least partially preserved
insulin secretion, but often insulin resistant.
 Some patients may have no clinical symptoms at all,
with diagnosis made exclusively on the basis of
laboratory results.
Diabetes Mellitus ( DM)
 Type one
 It is not genetically predetermined.
 Increase susceptibility to the diseases is inherited.
 Sibling has a 10 % chance of developing diabetes
by the age of 40.
 Susceptibility is associated with HLA genes ( HLA
DR3 and or DR4, DQ W)
Genetics of Diabetes
 Type two
 It is polygenic disorder ( no evidence of immune
involvement)
 Sibling have 50 % increased risk of developing
diabetes.
 Genes for majority of cases have yet to be
identified.
 Many genetic causes which include:
Mutations of insulin receptors
Deletion of mitochondrial DNA
Mutations effect the structure of insulin
Genetics of Diabetes
 In absence of insulin
 Hepatic glucose production accelerate
 Peripheral glucose uptake is reduced
 Hyperglycemia leads to
 Osmotic diuresis
 Loss of fluid and electrolytes
 Dehydration
 Plasma osmolality rises and renal perfusion falls
Metabolism in uncontrolled diabetes
 In parallel:
 Rapid lipolysis occurs
 Elevated circulatory FFA
 Rising ketogenesis
 Rising plasma ketone bodies which produce
metabolic acidosis
 Vomiting leads to further loss of fluid and
electrolytes
 Progressive dehydration impairs renal excretion of
hydrogen ions and ketones
Metabolism in uncontrolled diabetes
 Type I diabetes develop in young people, with the
peak incidence at approximately 12 years of age.
 It is caused by autoimmune destruction of pancreatic
B- cells. The precipitating cause is still unclear ( viral
infection initiate the chain of autoimmune reaction,
alternatively, cytokine response to viral infection, or
another insult, could attract monocytes and
macrophages that infiltrate and destroy the pancreatic
islets).
 A proportion of patients have antibodies against B- cell
proteins.
 Auto- antibodies to insulin are also seen in some
individuals.
Type I Diabetes
 Type 2 diabetes usually develop in patients who are
over 40 years old and are typically obese.
 The pathogenesis in type 2 diabetes involve the
impairment of insulin secretion and insulin resistance.
 The response of the diabetic B- cell to the glucose
stimulus is suboptimal and there is no first phase of
insulin secretion.
Type 2 Diabetes
 Diabeteic ketoacidosis, a sudden (acute ) metabolic
disturbance, is only one part of the diabetic syndrome.
 The other is the slow development of changes in small
(microangiopathy) and large (macroangiopathy)
arteries.
 Diabetic complications lead to diabetic kidney failure (
nephropathy), blindness ( retinopathy) and to the
impairment of nerve function ( neuropathy).
 Peripheral vascular disease is a major cause of foot
ulcers and lower limb amputations.
Long term complications of Diabetes
 Type 1: Daily subcutaneous insulin injections
throughout life. Patients in whom blood glucose is
difficult to control are treated with several injections
per day, or sometimes, with a constant insulin
infusion, delivered by a programmable, portable
pump. Diet and exercise are also important in the
management of diabetes.
 Type 2 : Diabetic patients do not usually require
insulin treatment because insulin synthesis is at least
partly preserved. Instead, the treatment relies on diet
and oral hypoglycemic agents. Drugs such as
sulfonylurea derivatives stimulate insulin secretion.
Another class of compounds ( metformin) reduce
hyperglycemia by increasing peripheral glucose
uptake.
Treatment of Diabetes:
 A 15 year old girl is admitted to the Accident and
Emergency department. She is confused and her breath
smells of acetone. She has dry skin and tongue, which
are signs of dehydration. She also takes quick, deep
breaths ( hyperventilation). Here RBG is 18.0 mmol/l (
324 mg/dl) and ketones are present in the urine. Her
serum potassium concentration is 3.5 mmol/l ( normal
3.5- 5.0 mmol/l) and her arterial blood pH is 7.2
( normal 7.37 – 7.44).
 Comment: this is a typical presentation of diabetic
ketoacidosis. Hyperventilation is a compensatory
response to acidosis. This patient needs to be treated as
a medical emergency. She will receive an intravenous
infusion containing physiologic saline with potassium
supplement to replace lost fluid, and an insulin infusion.
Typical presentation of diabetic ketoacidosis
Address four issues:
 Insulin infusion to reverse the metabolic effects of
the excess of anti- insulin hormones.
 Infusion of fluids to treat dehydration.
 Intravenous fluids normally contain potassium
supplements to prevent a decrease in plasma
potassium ( hypokalemia).
 When acidosis is severe, infusion of an alkaline
solution ( sodium bicarbonate) may be required.
Emergency treatment of diabetic ketoacidosis
 Insulin increases potassium uptake by cells. Lack of
insulin leads to release of potassium, particularly
from skeletal muscle. Since uncontrolled diabetes is
accompanied by an osmotic diuresis, the released
potassium is excreted through the kidney. Most
diabetic patients admitted to hospital with
ketoacidosis are potassium depleted. Exogenous
insulin given to such patients stimulates the entry of
potassium into cells. This further depletes the plasma
potassium pool and can lead to very low plasma
potassium level ( hypolkalemia). Hypokalemia is
dangerous, owing to its effects on cardiac muscle.
Thus, except for patients with very high potassium
level, potassium supplementation needs to be
considered in treatment of diabetic ketoacidosis.
Diabetic ketoacidosis and potassium
 Maintaining near normal blood glucose levels
prevents the development of late complications of
diabetes. A recently completed landmark clinical
study, the Diabetes Control Complications trial , has
shown that the development of late complications of
diabetes in type I diabetes is related to long term
glycemia. This study has also shown that in patients
who have complications, good control of glycemic
delays further development of retinopathy,
nephropathy and neuropathy. Similar results were
obtained for type 2 diabetic patients during the UK
Prospective Diabetes Study completed in 1998. Thus
the aim of treatment of diabetes should be the
achievement of blood levels as close to normal as
possible, without precipitating hypoglycemia.
The importance of good glycemic control
 The entry of glucose into brain, peripheral nerve
tissue, kidney, intestine, lens and RBC does not
depend on insulin action.
 During hyperglycemia, the intracellular level of
glucose in these cells is high, which promotes the
non- enzymatic attachment of glucose to protein
molecules.
 Glycation involves glucose and alpha- amino terminal
amino acid and ε- amino groups of lysine residues.
 Hemoglobin, albumin and collagen become glycated
which effects their function.
 For instance, glycation of apolipoprotein B slows
down the rate of receptor dependent metabolism of
LDL.
Protein modification by glucose
 The measurement of blood glucose remains the most
important laboratory test in diabetes.
 As erythrocytes age, there is gradual conversion of a
fraction of native hemoglobin ( HbA) to its glycated
form, HbA1C, so that an older red cell, a greater
fraction of HbA exist as HbA1C.
 HbA1C concentration in blood reflects the time –
averaged level of glycemia over the 3-6 weeks
preceding the measurement.
 The normal concentration of HbA1C is 4-6% of HbA.
Levels below 7% indicate acceptable control of
diabetes. Higher levels suggest poor control.
Glycated Hemoglobin (HbA1C)
 A 15 year old insulin dependent boy visited a Diabetic
Clinic for a check up. He tells the doctor that he
complies with all the dietary advice and never misses
insulin. Indeed, his random blood glucose is 6 mmol/l
( 108 mg/dl), but his HbA1C concentration is 11 % (
normal 4- 6 %). He has no glucosuria or ketones in
his urine.
 Comment: blood and urine glucose results indicate
good control of this boy’s diabetes at the time of
measurements, whereas the HbA1C level suggests
poor control over the last 3-6 weeks. The probability
is that he only complies with treatment days before
he was due to come to the clinic. This is not
uncommon in adolescent, who find it hard to accept
the necessity to adjust to their lifestyle to the
requirement of diabetes
HbA1C identifies patients who do not
comply with treatment
 Insulin consists of two chains linked by two
disulphide bonds. During insulin synthesis a signal
sequence is cleaved from pre proinsulin by a
peptidase, yielding proinsulin.
 Proinsulin consists of the insulin sequence
interspersed by a connecting peptide ( C – peptide).
At the final stage of insulin synthesis, proinsulin is
split into insulin and C- peptide released.
 C- peptide is released in an amount equimolar to
insulin. This is used to asses beta cell function in
patients treated with exogenous insulin.
 In these patients, endogenous insulin cannot be
measured directly, because the exogenous insulin
would interfere in the assay. In such circumstances,
C- peptide measurement provides an assessment of
beta cell function.
Insulin and C- peptide
 Glucose can be reduced to sorbitol by the action of aldose
reductase. Sorbitol is further oxidized by sorbitol
dehydrogenase to fructose. Since aldose reductase has a
high Km for glucose, the pathway is not very active at
normal glucose level.
 In hyperglycemia, however, glucose levels in insulin
independent tissues, such as the RBC, nerve and lens,
increase and consequently there is an increase in the activity
of the polyol pathway with depletion of NADPH.
 Like glucose, sorbitol exerts an osmotic effect. This is
thought to play a role in the development of diabetic
cataracts.
 In addition, the high level of sorbitol decreases cellular
uptake of another alcohol, myoinositol, which in turn causes
a decrease in the activity of membrane Na+/ K+ ATPase. This
in turn effects nerve function and, along with hypoxia and
reduced nerve blood, contributes to the development of
diabetic neuropathy. Drugs inhibiting aldose reductase
improve nerve function in diabetes.
The Polyol Pathway
 An apparently normal baby began to vomit and develop
diarrhea after breast feeding. These problems, together
with dehydration continued for several days, when the
baby began to refuse food and developed jaundice,
indicative of liver damage, followed by hepatomegaly and
then lens opacification ( cataracts). Measurements of
glucose in the blood and urine by specific enzymatic
technique indicated that levels of glucose were low,
consistent with the failure to absorb foods. However
glucose measured by a test that determined total
reducing sugar was eventually identified as galactose,
indicating an abnormality in galactose mechanism known
as galactosemia. This finding was consistent with the
observation that, when milk was removed from the diet
and replaced with an infant formula containing sucrose
rather than lactose, the vomiting and diarrhea stopped,
and hepatic function was gradually restored.
Galactosemia
 Comment: the accumulation of galactose in the blood is
most often a result of deficiency of Gal-1- P uridyl
transferase in liver tissues. Accumulation of the latter
interferes with phosphate and glucose metabolism,
leading to widespread tissue damage, organ failure, and
mental retardation. In addition, accumulation of
galactose in tissues results in galactose conversion via
polyol pathway to galactitol, and the accumulation of
galactitol in the lens results in osmotic stress and
formation of cataracts. A milder form of galctosemia is
caused by galactokinase deficiency.
Galactosemia
 A baby, born of poorly controlled, chronically hyperglycemic,
diabetic mother was large and chubby at birth ( 5kg.), but
appeared otherwise normal. He declined rapidly, however
and, within 1 hour showed all of the symptoms of
hypoglycemia, similar to the previously described case of baby
girl born of a malnourished mother. The difference, in this
case, was that the boy was thin, rather than heavy.
 Comment: This child has experienced a chronically
hyperglycemic environment during uterine development. He
adapted by increasing insulin, which has a GH like activity,
resulting in macrosomia. At birth, when placental delivery of
glucose ceases, he has a normal blood glucose level. However
his high blood insulin promotes glucose uptake into muscles
and adipose tissue. The resultant insulin induced
hypoglycemia leads to stress response, which was corrected
by glucose infusion. His ample body mass will provide good
blood supply from muscle proteins when gluconeogenesis is
activated at 1-2 days post partum.
Large child born of a diabetic mother
 An autosomal recessive condition, due to deficiency
of fructose – 1- phosphate aldolase. The defect
causes:
 Intracellular accumulation of fructose -1-
phosphate.
 Inhibition of fructokinase.
 Increased blood level of fructose.
 Inhibition of glycogen phosphorylase due to
depletion of Pi.
 Profound hypoglycemia.
Fructose intolerance
 A baby girl is irritable, sweaty and lethargic and
demands food frequently. Physical examination
indicates an extended abdomen, resulting from
enlarged liver. Blood glucose, after a meal, was 3.5
mmol/l (70 mg/ dl). After 4 h, the child was exhibiting
irritability and sweating, her heart rate was increased
and blood glucose had declined to 2 mmol/l ( 40
mg/dl). These symptoms were corrected by feeding. A
liver biopsy showed massive deposition of glycogen in
the liver cytosol.
 Comments: She has deficiency in glycogen
mobilization. Because of the severity of hypglycemia,
the most likely mutation is in hepatic glucose- 6-
phosphatase, which is required for glucose production
by both gluconeogenesis and glycogenolysis.
Von Gierk’s Disease
 A genetic recessive disorder, due to absence of
lysosomal glucosidase which results in
 Generalized (liver, heart and muscle)
 Excessive glycogen concentrations found in
abnormal vacuoles in the cytosol.
 Normal blood sugar
 Severe cardiomegaly
 Early death usually occurs
 Normal glycogen structure
Pompe’s disease
 A 30 year old man complains of chronic arm and leg
muscle pain and cramps during exercise. The pain
generally disappeared after about 15- 30 minutes, then
he could continue his exercise without discomfort. This
blood glucose level was normal during exercise, but his
serum creatine kinase (MM) was elevated. Blood glucose
declined slightly during exercise, but unexpectedly blood
lactate also declined, rather than increased, even when
he was experiencing muscle cramp. A biopsy indicated
an unusually high level of glycogen in muscle.
 Comment: this patient suffers from rare deficiency of
muscle phosphorylase activity. Since the patient did not
excrete lactate into the blood after intense exercise,
suggests a failure to mobilize muscle glycogen. His
recovery after half an hour results from epinephrine
mediated response that provides both glucose and fatty
acids from blood overcoming deficiency in muscle
glycogenolysis.
McArdle’s disease
 Just prior to planned departure to the tropics, a
patient visits his physician, complaining of weakness
and noting that his urine had recently become
unexplainably dark. Physical examination revealed
slightly jaundiced ( yellow, icteric ) sclera. Laboratory
tests indicated a low hematocrit, a high reticulocyte
count, and significantly increased blood level of
bilirubin. The patient has been quite healthy during a
previous visit a month ago when he received
immunizations and prescriptions for drugs related to
his travel plan
Glucose 6 phosphate dehydrogenase deficiency 1
 Comments: A number of drugs, particularly primaquine
and related antimalarials, undergo reactions in the cell,
producing large quantities of superoxide and H2O2.
Superoxide dismutase converts superoxide into H2O2,
which is inactivated by glutathione peroxidase using
NADPH. Some persons have genetic defect in G6PD,
typically yielding an unstable enzyme that has a
shorter life in the RBC. Therefore insufficient
production of NADPH under stress, the cell ability to
recycle GSSG to GSH is impaired and drug induced
oxidative stress leads to lysis of RBC’s and hemolytic
anemia. If the hemolysis is severe enough Hb spills
over into the urine, resulting in hematuria and dark
colored urine. Older cells, which can’t synthesize and
replace their enzyme are therefore particularly
affected. Genetically the deficiency is X- linked. Favism
is associated with G6PD deficiency.
Glucose 6 phosphate dehydrogenase deficiency 2
Carbohydrate Digestion and Metabolism
Carbohydrate Digestion and Metabolism
Carbohydrate Digestion and Metabolism

More Related Content

Similar to Carbohydrate Digestion and Metabolism

Carbohydrate metabolism.pptx
Carbohydrate metabolism.pptxCarbohydrate metabolism.pptx
Carbohydrate metabolism.pptxssuser004da6
 
Digestion & absorption of carbohydrate
Digestion & absorption of carbohydrateDigestion & absorption of carbohydrate
Digestion & absorption of carbohydratesakina hasan
 
Gluconeogenesis
GluconeogenesisGluconeogenesis
GluconeogenesisWITTYGOLD
 
11_Insulin_Glucagon_Thyroxine-1.pdf
11_Insulin_Glucagon_Thyroxine-1.pdf11_Insulin_Glucagon_Thyroxine-1.pdf
11_Insulin_Glucagon_Thyroxine-1.pdfZainabSiddiqui46
 
L3 - CH66 Absorption & Digestion.docx
L3 - CH66 Absorption & Digestion.docxL3 - CH66 Absorption & Digestion.docx
L3 - CH66 Absorption & Digestion.docxAmeerahAbbas
 
Carbohydrate metabolism an overview
Carbohydrate metabolism an overviewCarbohydrate metabolism an overview
Carbohydrate metabolism an overviewRamesh Gupta
 
Carbohydrate & lipid metabolism in children age, semiotics of disturbances
Carbohydrate & lipid metabolism in children age, semiotics of disturbancesCarbohydrate & lipid metabolism in children age, semiotics of disturbances
Carbohydrate & lipid metabolism in children age, semiotics of disturbancesEneutron
 
Glucose regulation
Glucose regulationGlucose regulation
Glucose regulationSng Kim Sia
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitusghadimhmd
 
Digestion & absorption of carbohydrates
Digestion & absorption of carbohydratesDigestion & absorption of carbohydrates
Digestion & absorption of carbohydratesAnsil P N
 
Digestion and absorption of carbohydrates
Digestion and absorption of carbohydratesDigestion and absorption of carbohydrates
Digestion and absorption of carbohydratesAmmar Elmajzoup
 
Diegestion Absorption of CHO and Hexose sugar metabolism.pdf
Diegestion Absorption of CHO and Hexose sugar metabolism.pdfDiegestion Absorption of CHO and Hexose sugar metabolism.pdf
Diegestion Absorption of CHO and Hexose sugar metabolism.pdfTeshaleTekle1
 
Bioc hemistry_ Regulation and integration of Metabolism
Bioc hemistry_ Regulation and integration of MetabolismBioc hemistry_ Regulation and integration of Metabolism
Bioc hemistry_ Regulation and integration of MetabolismPrabesh Raj Jamkatel
 
Carbohydrate digestion
Carbohydrate digestionCarbohydrate digestion
Carbohydrate digestionAli Mehdi
 
002 carbohydrate Metabolism 1.ppt
002 carbohydrate Metabolism 1.ppt002 carbohydrate Metabolism 1.ppt
002 carbohydrate Metabolism 1.pptMutaiKiprotich4
 

Similar to Carbohydrate Digestion and Metabolism (20)

Carbohydrate metabolism.pptx
Carbohydrate metabolism.pptxCarbohydrate metabolism.pptx
Carbohydrate metabolism.pptx
 
Digestion & absorption of carbohydrate
Digestion & absorption of carbohydrateDigestion & absorption of carbohydrate
Digestion & absorption of carbohydrate
 
Gluconeogenesis
GluconeogenesisGluconeogenesis
Gluconeogenesis
 
11_Insulin_Glucagon_Thyroxine-1.pdf
11_Insulin_Glucagon_Thyroxine-1.pdf11_Insulin_Glucagon_Thyroxine-1.pdf
11_Insulin_Glucagon_Thyroxine-1.pdf
 
L3 - CH66 Absorption & Digestion.docx
L3 - CH66 Absorption & Digestion.docxL3 - CH66 Absorption & Digestion.docx
L3 - CH66 Absorption & Digestion.docx
 
Carbohydrate metabolism an overview
Carbohydrate metabolism an overviewCarbohydrate metabolism an overview
Carbohydrate metabolism an overview
 
Pathophis of carbohydrates and lipids metabolism
Pathophis of carbohydrates and lipids metabolismPathophis of carbohydrates and lipids metabolism
Pathophis of carbohydrates and lipids metabolism
 
Carbohydrate & lipid metabolism in children age, semiotics of disturbances
Carbohydrate & lipid metabolism in children age, semiotics of disturbancesCarbohydrate & lipid metabolism in children age, semiotics of disturbances
Carbohydrate & lipid metabolism in children age, semiotics of disturbances
 
Glucose regulation
Glucose regulationGlucose regulation
Glucose regulation
 
Basics of Insulin
Basics of InsulinBasics of Insulin
Basics of Insulin
 
Insulin, glucagon & dm
Insulin, glucagon & dmInsulin, glucagon & dm
Insulin, glucagon & dm
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
carbohydrates
carbohydratescarbohydrates
carbohydrates
 
Digestion & absorption of carbohydrates
Digestion & absorption of carbohydratesDigestion & absorption of carbohydrates
Digestion & absorption of carbohydrates
 
Digestion and absorption of carbohydrates
Digestion and absorption of carbohydratesDigestion and absorption of carbohydrates
Digestion and absorption of carbohydrates
 
Diegestion Absorption of CHO and Hexose sugar metabolism.pdf
Diegestion Absorption of CHO and Hexose sugar metabolism.pdfDiegestion Absorption of CHO and Hexose sugar metabolism.pdf
Diegestion Absorption of CHO and Hexose sugar metabolism.pdf
 
Bioc hemistry_ Regulation and integration of Metabolism
Bioc hemistry_ Regulation and integration of MetabolismBioc hemistry_ Regulation and integration of Metabolism
Bioc hemistry_ Regulation and integration of Metabolism
 
Carbohydrate digestion
Carbohydrate digestionCarbohydrate digestion
Carbohydrate digestion
 
!!!Glycolysis, neoglucogenesis, the anaerobic degradation of glucose
!!!Glycolysis, neoglucogenesis, the anaerobic degradation of glucose!!!Glycolysis, neoglucogenesis, the anaerobic degradation of glucose
!!!Glycolysis, neoglucogenesis, the anaerobic degradation of glucose
 
002 carbohydrate Metabolism 1.ppt
002 carbohydrate Metabolism 1.ppt002 carbohydrate Metabolism 1.ppt
002 carbohydrate Metabolism 1.ppt
 

More from AnnaKhurshid

12222432.ppt amino acid & protein metabolism
12222432.ppt  amino acid & protein metabolism12222432.ppt  amino acid & protein metabolism
12222432.ppt amino acid & protein metabolismAnnaKhurshid
 
8402594 pm.ppt metabolism of amino acids
8402594 pm.ppt metabolism of amino acids8402594 pm.ppt metabolism of amino acids
8402594 pm.ppt metabolism of amino acidsAnnaKhurshid
 
4043247.ppt biochemistry of water & electrolyte
4043247.ppt biochemistry of water & electrolyte4043247.ppt biochemistry of water & electrolyte
4043247.ppt biochemistry of water & electrolyteAnnaKhurshid
 
fluidandelectrolyteimbalance-180131131237.ppt
fluidandelectrolyteimbalance-180131131237.pptfluidandelectrolyteimbalance-180131131237.ppt
fluidandelectrolyteimbalance-180131131237.pptAnnaKhurshid
 
celiac disease 0r gluten enteropathy ppty
celiac disease 0r gluten enteropathy pptyceliac disease 0r gluten enteropathy ppty
celiac disease 0r gluten enteropathy pptyAnnaKhurshid
 
10560062.ppt biochemistry of respiratory system
10560062.ppt biochemistry of respiratory system10560062.ppt biochemistry of respiratory system
10560062.ppt biochemistry of respiratory systemAnnaKhurshid
 
NB.ppt biochemistry of amino acid & proteins
NB.ppt biochemistry of amino acid & proteinsNB.ppt biochemistry of amino acid & proteins
NB.ppt biochemistry of amino acid & proteinsAnnaKhurshid
 
newmicrosoftpowerpointpresentation-201231054717.pptx
newmicrosoftpowerpointpresentation-201231054717.pptxnewmicrosoftpowerpointpresentation-201231054717.pptx
newmicrosoftpowerpointpresentation-201231054717.pptxAnnaKhurshid
 
carbon monoxide poisoning ppt forensic medicine
carbon monoxide poisoning ppt forensic medicinecarbon monoxide poisoning ppt forensic medicine
carbon monoxide poisoning ppt forensic medicineAnnaKhurshid
 
ards-230220035206-3eb572a7 respiratory distress syndrome.pptx
ards-230220035206-3eb572a7 respiratory distress syndrome.pptxards-230220035206-3eb572a7 respiratory distress syndrome.pptx
ards-230220035206-3eb572a7 respiratory distress syndrome.pptxAnnaKhurshid
 
organophosphate poisoning1 medicne..pptx
organophosphate poisoning1 medicne..pptxorganophosphate poisoning1 medicne..pptx
organophosphate poisoning1 medicne..pptxAnnaKhurshid
 
5682673.ppt biochemistry of lipid metabolism
5682673.ppt biochemistry of lipid metabolism5682673.ppt biochemistry of lipid metabolism
5682673.ppt biochemistry of lipid metabolismAnnaKhurshid
 
mygeneticspresentation-141130173403-conversion-gate02.pptx
mygeneticspresentation-141130173403-conversion-gate02.pptxmygeneticspresentation-141130173403-conversion-gate02.pptx
mygeneticspresentation-141130173403-conversion-gate02.pptxAnnaKhurshid
 
Anatomy, physiology, biochemistry of GIT.ppt
Anatomy, physiology, biochemistry of GIT.pptAnatomy, physiology, biochemistry of GIT.ppt
Anatomy, physiology, biochemistry of GIT.pptAnnaKhurshid
 
PUD.pptx peptic ulcer disease biochemistrymedicine
PUD.pptx peptic ulcer disease biochemistrymedicinePUD.pptx peptic ulcer disease biochemistrymedicine
PUD.pptx peptic ulcer disease biochemistrymedicineAnnaKhurshid
 
l5nr-171221075659.pptxbiochemistryyyyyyy
l5nr-171221075659.pptxbiochemistryyyyyyyl5nr-171221075659.pptxbiochemistryyyyyyy
l5nr-171221075659.pptxbiochemistryyyyyyyAnnaKhurshid
 
xerostromia.ppt biochemistry of git tract
xerostromia.ppt biochemistry of git tractxerostromia.ppt biochemistry of git tract
xerostromia.ppt biochemistry of git tractAnnaKhurshid
 
Acid base balance slides-biochemistry.ppt
Acid base balance slides-biochemistry.pptAcid base balance slides-biochemistry.ppt
Acid base balance slides-biochemistry.pptAnnaKhurshid
 
enzymes-160517003157.pptxbiochemistryyyy
enzymes-160517003157.pptxbiochemistryyyyenzymes-160517003157.pptxbiochemistryyyy
enzymes-160517003157.pptxbiochemistryyyyAnnaKhurshid
 
organophosphoruspoisoningfinal-170803080008.pptx
organophosphoruspoisoningfinal-170803080008.pptxorganophosphoruspoisoningfinal-170803080008.pptx
organophosphoruspoisoningfinal-170803080008.pptxAnnaKhurshid
 

More from AnnaKhurshid (20)

12222432.ppt amino acid & protein metabolism
12222432.ppt  amino acid & protein metabolism12222432.ppt  amino acid & protein metabolism
12222432.ppt amino acid & protein metabolism
 
8402594 pm.ppt metabolism of amino acids
8402594 pm.ppt metabolism of amino acids8402594 pm.ppt metabolism of amino acids
8402594 pm.ppt metabolism of amino acids
 
4043247.ppt biochemistry of water & electrolyte
4043247.ppt biochemistry of water & electrolyte4043247.ppt biochemistry of water & electrolyte
4043247.ppt biochemistry of water & electrolyte
 
fluidandelectrolyteimbalance-180131131237.ppt
fluidandelectrolyteimbalance-180131131237.pptfluidandelectrolyteimbalance-180131131237.ppt
fluidandelectrolyteimbalance-180131131237.ppt
 
celiac disease 0r gluten enteropathy ppty
celiac disease 0r gluten enteropathy pptyceliac disease 0r gluten enteropathy ppty
celiac disease 0r gluten enteropathy ppty
 
10560062.ppt biochemistry of respiratory system
10560062.ppt biochemistry of respiratory system10560062.ppt biochemistry of respiratory system
10560062.ppt biochemistry of respiratory system
 
NB.ppt biochemistry of amino acid & proteins
NB.ppt biochemistry of amino acid & proteinsNB.ppt biochemistry of amino acid & proteins
NB.ppt biochemistry of amino acid & proteins
 
newmicrosoftpowerpointpresentation-201231054717.pptx
newmicrosoftpowerpointpresentation-201231054717.pptxnewmicrosoftpowerpointpresentation-201231054717.pptx
newmicrosoftpowerpointpresentation-201231054717.pptx
 
carbon monoxide poisoning ppt forensic medicine
carbon monoxide poisoning ppt forensic medicinecarbon monoxide poisoning ppt forensic medicine
carbon monoxide poisoning ppt forensic medicine
 
ards-230220035206-3eb572a7 respiratory distress syndrome.pptx
ards-230220035206-3eb572a7 respiratory distress syndrome.pptxards-230220035206-3eb572a7 respiratory distress syndrome.pptx
ards-230220035206-3eb572a7 respiratory distress syndrome.pptx
 
organophosphate poisoning1 medicne..pptx
organophosphate poisoning1 medicne..pptxorganophosphate poisoning1 medicne..pptx
organophosphate poisoning1 medicne..pptx
 
5682673.ppt biochemistry of lipid metabolism
5682673.ppt biochemistry of lipid metabolism5682673.ppt biochemistry of lipid metabolism
5682673.ppt biochemistry of lipid metabolism
 
mygeneticspresentation-141130173403-conversion-gate02.pptx
mygeneticspresentation-141130173403-conversion-gate02.pptxmygeneticspresentation-141130173403-conversion-gate02.pptx
mygeneticspresentation-141130173403-conversion-gate02.pptx
 
Anatomy, physiology, biochemistry of GIT.ppt
Anatomy, physiology, biochemistry of GIT.pptAnatomy, physiology, biochemistry of GIT.ppt
Anatomy, physiology, biochemistry of GIT.ppt
 
PUD.pptx peptic ulcer disease biochemistrymedicine
PUD.pptx peptic ulcer disease biochemistrymedicinePUD.pptx peptic ulcer disease biochemistrymedicine
PUD.pptx peptic ulcer disease biochemistrymedicine
 
l5nr-171221075659.pptxbiochemistryyyyyyy
l5nr-171221075659.pptxbiochemistryyyyyyyl5nr-171221075659.pptxbiochemistryyyyyyy
l5nr-171221075659.pptxbiochemistryyyyyyy
 
xerostromia.ppt biochemistry of git tract
xerostromia.ppt biochemistry of git tractxerostromia.ppt biochemistry of git tract
xerostromia.ppt biochemistry of git tract
 
Acid base balance slides-biochemistry.ppt
Acid base balance slides-biochemistry.pptAcid base balance slides-biochemistry.ppt
Acid base balance slides-biochemistry.ppt
 
enzymes-160517003157.pptxbiochemistryyyy
enzymes-160517003157.pptxbiochemistryyyyenzymes-160517003157.pptxbiochemistryyyy
enzymes-160517003157.pptxbiochemistryyyy
 
organophosphoruspoisoningfinal-170803080008.pptx
organophosphoruspoisoningfinal-170803080008.pptxorganophosphoruspoisoningfinal-170803080008.pptx
organophosphoruspoisoningfinal-170803080008.pptx
 

Recently uploaded

Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 

Recently uploaded (20)

Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 

Carbohydrate Digestion and Metabolism

  • 1.
  • 2.  Carbohydrates are the largest source of dietary calories.  The major carbohydrates are starch, lactose and sucrose  The main carbohydrates in body metabolism is glucose  transported to muscle (and other tissues) via blood  stored in liver and muscle as glycogen  ATP produced more quickly from CHO than from fats or proteins  CHO stores can be depleted Carbohydrates (Fuels)
  • 3. Digestion  Starch digestion begins in mouth by the salivary α-amylase which converts starch to smaller polysaccharides called α-dextrins  Pancreatic α-amylase continue the digestion of α-dextrins into maltose, maltotriose & oligosaccharides called limited dextrins  Digestion of maltose, maltotriose, sucrose & lactose continues by disaccharidases attached to the membrane of surface of the brush border (microvilli)of intestinal epithelial cells  The monosaccharides produced are transported into the intestinal cells
  • 4. Sucrase-isomaltase complex  Similar to glucosamylase attached to membrane with two polypeptides. Protrudes into the intestinal lumen, an intestinal protease clips in into two separate subunits that remain attached to each other. Each subunit site has a catalytic site that differs in substrate specificity. The sucrase-maltase site accounts for 100% of intestinal ability to hydrolyze sucrose in addition to maltase activity. The isomaltase-maltase site accounts for almost all activity to hydrolyze α 1- 6 bonds in addition to maltase activity.
  • 5. Trehalase & Lactase  Trehalase: One catalytic site & hydrolyzes the glycosidic bond in trehalose (disaccharide of two glucosyl units attached by their anomeric carbons.  Lactase - Glucosyl cermidase Complex: Glycoprotein found in the brush border that has two caralytic sites extending in the intestinal lumin. It hydrolyzes lactose and the B-bonds between glucose or galactose and ceramide in glycolipids.
  • 6. Dietary Fiber  Composed principally of polysaccharides which can not be digested by human enzymes of intestinal tract  Derivatives of lignan ( cellulose, hemicellulose, lignin, pectin s, mucilages & gums)  Bacterial flora of the colon metabolize the fibers to gases(H2,CO2,CH4) & short chain fatty acids  Fatty acids are absorbed by colonic cells  Fibers is seen to soften the stool, thereby reducing pressure on colonic wall & enhancing expulsion of feces
  • 7. Glucose Absorption  Two types of glucose transport proteins are present in the intestinal cells – Na+ dependent: an active transport which depends on cotransport of sodium and glucose – Facilitated : passive transport known as Glut 1 -4
  • 8.  Cell membranes are not inherently permeable to glucose. There are many glucose transporters.  GLUT- 1 enables basal non- insulin stimulated glucose uptake (erythrocytes)  GLUT- 2 transport glucose into beta cells, a pre- requisite for glucose sensing.  GLUT- 3 enables non- insulin mediated glucose uptake into brain.  GLUT- 4 enables much of the peripheral action of insulin (muscles, adipose) Glucose transporters
  • 9. Absorption of carbohydrates  Sugars are transported across the intestinal epithelial cells into the blood  Not all complex sugars are digested in the same rate within the intestine  Glycemic index of the food is an indication of how rapidly blood glucose level rises after consumption Whole weat 100 pasta 67 cornflakes 121 potatoes 120 Ice cream 69 fruits 52
  • 10. The waiting room  Deria Voider is a 20 year old exchange student from Nigeria who has noted gastrointestinal bloating, abdominal cramps, and intermittent diarrhea ever since arriving in the united states 6 months earlier. A careful history shows that these symptoms occur most commonly about 45 minutes to 1 hour after eating breakfast but may occur after other meals as well. Dairy products, not a part of Deria’s diet in Nigeria, were identified as the probable offending agent because her gastrointestinal symptoms disappeared when milk & milk products were eliminated from here diet.
  • 11. The waiting room  Lactose intolerance can either be the result of a primary deficiency of lactase production in the small bowel or it can be secondary to an injury to the intestinal mucosa, where lactase is normally produced.  The lactose that is not absorbed is converted by colonic bacteria to lactic acid . Methane gas and H2 gas  The osmotic effect of lactose & lactic acid in the bowel lumen is responsible for the diarrhea seen often
  • 12.  A 15 year old complained of abdominal discomfort, a feeling of bloated, increase passage of urine, more recently, the development of diarrhea. His only change in diet noted at the time was the introduction of yogurt into his diet. He was consuming 1-2 large cartons per day. A lactose test was performed, whereby the young man was given 50 g lactose in an aqueous vehicle to drink. Plasma glucose levels did not rise by more than 1 mmol/ l ( 18g /dl) over the next 2 hour, with sampling at 30 minutes interval. A diagnosis of lactose intolerance was made.  Comment: This is due to deficiency of lactase. Lactase activity decreases with age in children but this decline is genetically predetermined. A diagnosis is made by challenging the small bowel with lactose and monitoring the rise in plasma glucose. An increase of more than 1.7 mmol/l (30 g/dl) is considered normal. Lactose intolerance
  • 14.
  • 15. Glycogenolysis  Occurs mainly in liver & muscles  Both pathways in the liver & muscle are the same  End product in liver is glucose, while in muscle is glucose 6 phosphate
  • 16.
  • 17.
  • 18.
  • 19.
  • 20. Regulation of Glycogen Metabolism in Liver  When blood glucose level increases immediately after a meal, insulin level increases, whole glycogen level decreases.  Increase in insulin/glycogen ration inhibits glycogenolysis & stimulates glycogenesis.  The immediate removal of blood glucose helps bring circulating blood glucose levels back to normal 80-100 mg/dl range.  Postprandilly, insulin levels decrease & glucagon levels increase.  The fall of the insulin/glycogen ratios results in inhibition of glycogenesis and increased glycogenolysis.  Substantial proportion of liver glycogen is degraded within the few first hours after eating.
  • 21.
  • 22. Regulation of Glycogenolysis & Glycogenesis in Skeletal Muscle  Skeletal muscle glycogen is degraded only when the demand for ATP generation is high.  Regulation of glycogen metabolism differs from that in liver. 1. Glucagon has no effect (muscle glycogen do not vary with fasting/feeding state) 2. AMP is an alosteric activator of muscle glycogen phosphorylase but not liver isozyme. 3. Glucose is not a physiological inhibitor of glycogen phosphorylase. 4. Epinephrine effects are similar to that in liver.
  • 23. Epinephrine & Ca2+ in the Regulation of Liver Glycogen  Epinephrine released from adrenal medulla in response to neural signals reflecting an increased demand for glucose.  Epinephrine stimulated glycogenolysis in liver through two different receptors. – B-Receptors: transmit a signal through G- protein to adenylate cyclase, which increases cAMP. – Α-Receptors: increases CA2+ levels in the liver, which is mediated by the phosphatidylinositol bisphosphate - CA2+ signal transduction system.
  • 24. Function of glycogen in Skeletal Muscle & Liver  It functions as a reservoir of glucosyl units for ATP generation.  Glycogen is usually degraded to glucose-1- phosphate which is converted into glucose-6- phosphate.  In skeletal muscles and other cell types, glucose-6- phosphate is used by the cell to produce ATP (Absence of glucose-6-phosphatase).  In liver, glycogen serves a very different purpose. Liver glycogen is the first and immediate source of glucose for the maintenance of blood glucose level. In liver, glucose-6-phosphate is converted to free glucose by G-6-phosphatase, present only liver and kidneys.
  • 25. Futile Cycles  Regulation of glycogen synthesis serves to prevent futile cycling and waste of ATP.  Futile cycle refers to a situation in which a substrate is converted to a product through one pathway & the product converted back to the substrate through another pathway.  Because biosynthesis pathway is energy requiring, futile cycling results in a waste of high energy phosphate bonds.  Therefore, glycogenesis is activated when glycogenolysis is inhibited and vice versa.
  • 26. The Waiting Room (1) A newborn baby girl, Getta Garbo, was born after a 38-week gestation. Her mother, a 36- year-old woman, had moderate hypertension during the last trimester of pregnancy related to a recurrent urinary tract infection that resulted in a severe loss of appetite and recurrent vomiting in the month preceding delivery. Fetal bradycardia (slower than normal feta heart rate) was detected with each uterine contraction of labor, a sign of possible fetal distress. At birth Getta was cyanotic (a bluish discoloration caused by lack of adequate oxygenation of tissues) and limp. She responded to several minutes of assisted ventilation.
  • 27. The Waiting Room (2) Physical examination in the nursery at 10 minutes, showed a thin, malnourished female newborn. Her body temperature was slightly low, her heart rate was rapid and her respiratory rate of 35 breaths/minute was elevated. Getta’s birth weight was only 2,100g (normal 3,300 g). Her length was 47 cm, and her head circumference was 33cm (low normal). Getta’s serum glucose when she was unresponsive was 14 mg/dL. (glucose below 40 mg/dL (2.5 mM) is abnormal in newborn). At 5 hours of age, she was apneic (not breathing) and unresponsive. Ventilatory resuscitation was initiated and a cannula placed in the umbilical vein. Blood for a glucose level was drawn through this cannula, and 5mL of a 20% glucose solution was injected. Getta slowly responded to this therapy.
  • 28. The Waiting Room (3) Maternal blood glucose readily crosses the placenta to enter the fetal circulation. During the last 9 or 10 weeks of gestation, glycogen formed from maternal glucose is deposited in the fetal liver under the influence of the insulin-dominated hormonal milieu of that period. At birth, maternal glucose supplies cease, causing a temporary physiologic drop in glucose levels in the newborn’s blood even in normal healthy infants. This drop serves as one of the signals for glucagon release from the newborn’s pancreas, which, in turn stimulates glycogenolysis. As a result, the glucose levels in the newborn return to normal. Healthy full-term babies have adequate stores of liver glycogen to survive short (12 hours) periods of caloric deprivation provided other aspects of fuel metabolism are normal. Because Getta Garbo’s mother was markedly anorexic during the critical period when the fetal liver is normally synthesizing glycogen from glucose supplied in the maternal blood, Getta’s liver glycogen is the major source of fuel for the newborn in the early hours of life, Getta became profoundly hypoglycemic within 5 hours of birth because of her low levels of stored carbohydrates.
  • 29. electron transport chain Aerobic Metabolism Oxidation Phosphorylation Kreb’s cycle Glycolysis (carbohydrates) (proteins) Beta Oxidation (fats) NADH FADH2 O2 H2O ADP + Pi ATP acetyl CoA mitochondria oxidation phosphorylation
  • 31.  uses only CHO  occurs in sarcoplasm  first step is glucose transport into tissues  after entry, 2 ATP are used (with glucose)  glucose (C6) is split into two C3 molecules  final product is pyruvate  4 ATP are synthesized  pyruvate forms either lactate or enters mitochondria Glycolysis
  • 32. Functions of Glycolysis  ATP Production  Synthesis of UDP-glucose, sialic acid & mannosa  Synthesis of serine & alanine  Synthesis of TG from DHAP & fatty acids  In RBC, synthesis 2,3 DPG
  • 33. glucose ATP ATP PFK 4 ATP pyruvate lactate acetyl CoA mitochondria glycogenolysis sarcolemma blood glycolysis Overview of Glycolysis
  • 35.
  • 36.
  • 37.
  • 38. Lactate Production  Major tissue sites of lactate production in a resting man (g/day) RBC 29 Skin 20 Brain 17 Skeletal muscles 16 Renal medulla 15 Intestinal mucosa 8 Other tissues 10 Total Production 115
  • 39. Electron Transport Chain (ETC) Oxidative Phosphorylation Oxidation  NADH and FADH2 transfer electrons to ETC  final acceptor of electrons is O2 Phosphorylation  energy generated by oxidation used to resynthesize ATP – 3 ATP from each NADH – 2 ATP from each FADH2
  • 40. 1,3 DPG 2,3 DPG mutase 2,3 DPG 2,3 DPG phosphatase 2-PG 2,3 DPG synthesis & degradation ADP ATP
  • 41.
  • 42. Regulation of Glycolysis  Hexokinase inhibited by G-6-P with low km for glucose  PFk-1 is the rate limiting enzyme activated by AMP and Fructose-2-6 bisphosphate (alosteric)  PFK-1 inhibited by ATP & citrate.  Pyruvate kinase present in brain and skeletal muscles has no alosteric site & hence does not contribute toward regulation of glycolysis in these tissues.  Liver pyruvate kinase is inhibited by phosphorylation (CAMP) & alosterically inhibited by ATP.
  • 43.
  • 44.
  • 45.
  • 46. Dental Caries  Ivan Applebod is a 56-year-old morbidly obese accountant. He decided to see his dentist because he felt excruciating pain in his teeth when he ate ice-cream. He really likes sweets and keeps hard candy in his pocket. The dentist noted from Mr. Applebod’s history that he had numerous cavities as a child in his baby teeth. At this visit, the dentist found cavities in two of Mr. Applebod’s teeth.
  • 47. Comment  The dental caries in Ivan Applebod’s mouth were case principally by the low ph generated from lactic acid production by oral bacteria. Below a ph of 5.5 decalcification of tooth enamel & dentine occurs. Lactobacilli and s. mutants are major contributors to this process because almost all of their energy is derived from the conversion of glucose or fructose to lactic acid, and they are able to form well at low ph generated by this process. The dentist explained that bacteria in his dental plaque could convert all the sugar in his candy into acid in less than 20 minutes. The acid is buffered by bicarbonate & other buffers in saliva, by saliva production decreases in the evening. Thus, the acid could dissolve the hyroxyapptite in his tooth enamel during the night.
  • 48.  lactate formation  enters mitochondria (i.e. Kreb’s cycle)  formation of Kreb’s cycle intermediates Pyruvate goes in one of three directions Metabolic Fate of Pyruvate
  • 49.
  • 50.
  • 52.  primary function is to reduce NAD+ and FAD  acetyl CoA (C2) combines with a C4 molecule forming a C6 molecule  C6 molecule is partially degraded back to a C4 molecule  each loss of C gives off a CO2 Kreb’s Cycle (Citric Acid Cycle)
  • 53.
  • 54.
  • 55.
  • 56. electron transport chain Overview of Aerobic Metabolism Kreb’s cycle (proteins) NADH FADH2 O2 H2O ADP + Pi ATP acetyl CoA 1. Preparation for entry into Kreb’s cycle 2. Removal of “energized” electrons 3. 1º ATP synthesis; Oxidation- phosphorylation mitochondria Beta Oxidation (fats) Glycolysis (carbohydrates)
  • 58.  Sites include liver & kidney while substrates include, amino acids, lactate, pyruvate, glycerol.  Cori & alanine cycles for transport of intermediates between site of production of these metabolites and site of synthesis.  Many enzymes of glycolysis are common to gluconeogenesis. Gluconeogenesis(1)
  • 59.
  • 60.  Irrversible enzymes of glycolysis are replaced by gluconeogenesis enzymes. 1. Pyruvate kinase – pyruvate carboxylase & PEPCK 2. PFK ---- F 2,6 diphosphatase 3. Glucokinase --- Glu 6 phosphatase Gluconeogenesis(2)
  • 61. Gluconeogenesis - Bypass Enzymes Glucose oxaloacetate Glucose-6-Phosphate Fructose-6-Phosphate Fructose 1,6 Bisphosphate DHAP + Glyceraldehyde-3-P Glyceraldehyde-3-P Pyruvate PEP 2-Phosphoglycerate 3-Phosphoglycerate 1,3-BPG
  • 62. Gluconeogenesis - Bypass Enzymes pyruvate + CO2 + ATP + H2O  oxaloacetate + ADP,Pi + 2H+ oxaloacetate + GTP  PEP + GDP + CO2 10. Pyruvate carboxylase & PEP carboxykinase (+) acetylCoA & (-) ADP 3.Fructose 1,6-bisphosphatase (-) fructose 2,6-bisphosphate (low fasting – high Fed) (-) AMP fructose 1,6 bisphosphate + H2O  fructose 6-phosphate + Pi 1. Glucose 6-phosphatase glucose 6-phosphate + H2O  glucose + Pi
  • 63. GLUCONEOGENESIS Liver 2Pyruvate + 4ATP + 2NADH 2GTP Glucose + 4ADP + 2NAD+ 2GDP to blood
  • 64.  Galactose metabolism occurs in liver.  Galactose UDP-galactose GK Uridyl transferase UDP- glucose Galactose metabolism
  • 65.  Occurs in liver & adipose tissue  Fructose Fructose 6 phos fructokinase Glucose 6 phos Fructose metabolism
  • 66.  The plasma glucose concentration reflects the balance between intake, tissue utilization & endogeneous production .  Insulin promotes up take of glucose thus decreasing plasma glucose while glucagon stimulates both the release of glucose from glycogen stores & its denovo synthesis, thus causing an increase in plasma glucose.  Glucose stimulates the secretion of insulin & suppresses the secretion of glucagon. Glucose Homeostasis
  • 67.  Insulin acts on three main targets, liver, adipose & muscles.  In liver insulin stimulates, glycolysis, glycogenesis & lipogenesis & suppresses lipolysis.  In peripheral tissues, insulin induces lipoprotein lipase activity & thus stimulates triglyceride synthesis.  In muscles, insulin increases glucose & amino acid transport & glycogen synthesis. Metabolic effects of insulin
  • 68.  Glucagon main effect is the mobilization of the fuel reserves for the maintenance of the blood glucose level between meals.  Glucagon inhibits glucose- utilizing pathways and the storage of metabolic fuels.  It acts on liver, to stimulate glycogenolysis and inhibit glycogenesis, glycolysis and lipogenesis.  Gluconeogenesis and ketogenesis are then activated  Epinephrine has effects similar to glucagon in the liver but works through a different receptor. It promotes an increase in blood glucose in response to stress Metabolic effects of Glucagon
  • 69.  The glucose level in the vicinity of the B- cell is sensed by the transporter GLUT- 2. Glucose is carried into the cell, where it is phophorylated into G-6- P by glucokinase which also is a part of the glucose sensing mechanism. Increased G-6- P increases glucose utilization and ATP production in the B- cell. This changes the flux of ions across the cell membrane, depolarizes the cell and increases the concentration of Ca2+. Hence insulin is exocytosed.  Insulin secretion is biphasic. The first phase occurs over 10- 15 minutes of stimulation which release the preformed insulin. The second phase, which lasts up to 2 hours, is the release of newly synthesized insulin. Stimulation of insulin secretion by glucose
  • 70.  Insulin secretion is also stimulated by gastrointestinal hormones (insulinotropic peptide, cholecystokinin) and amino acids, such as leucine, arginine, and lysine. Thus, the insulin response to orally administered glucose is greater than to an intravenous infusion. Stimulation of insulin secretion by glucose
  • 71.  Hypoglycemia is defined as a blood glucose concentration below 2.5 mmol/ L ( 45 mg/dl).  Epinephrine and glucagon are released, resulting in a stress response, the manifestation of which may include sweating, trembling, increased heart rate and feeling of hunger. If blood glucose continues to fall, brain function is compromised (neuroglycopenia).  Hypoglycemia in healthy individuals is usually mild and may occur during exercise, after a period of fasting or due to alcohol ingestion.  Hypoglycemia may be caused by a rare insulin secreting tumor of the beta- cells ( insulinoma) or overdose of exogenous insulin. Hypoglycemia
  • 72.  A 12 year old diabetic boy was playing with his friends. He received his normal insulin injection in the morning but continued playing through the lunch time without a meal. He became confused and fainted. He was instantly given an injection of glucagon from the emergency kit his father carried, and recovered within minutes.  Comment : An immediate improvement after glucagon injection confirms this boy’s symptoms were caused by hypoglycemia ,caused by the exogenous insulin and insufficient food intake. Spectacular recovery from hypoglycemia was due to the action of glucagon. In hospital, hypoglycemic patients who can not eat or drink are treated with an intravenous infusion of glucose. An intramuscular glucagon injection is an emergency measure that can be applied at home. Severe hypoglycemia is a medical emergency
  • 73.  A middle aged man, emaciated, chronic alcoholic collapsed and was transported to ER. Physical examination revealed a somewhat clammy skin, unusual for winter morning, rapid breathing and a rapid heart rate. Laboratory tests indicate a blood sugar of 2.5 mmol/l ( 50g/dl), and a blood alcohol level of 0.2 %. Subsequent tests indicated a normal level of CPK, high serum level of AST, a slight acidic pH (7.29), low pCO2 and high blood lactate. The man responded to infusion of a glucose solution & regained consciousness.  Comment: This patient probably had not eaten breakfast before starting his morning drinking. His glycogen stores were negligible, so he was dependent on gluconeogenesis for maintenance of blood glucose concentration, but gluconeogenesis may be compromised both by liver damage and by limited muscle mass Alcohol Excess and Hypoglycemia-1
  • 74.  Alcohol is metabolized primarily in the liver. Two steps metabolism of alcohol is relatively unregulated, leading to a rapid increase in hepatic NADH. This shifts the equilibrium of LDH catalyzed reaction towards lactate formation ( lacticacidemia). Also shifts cytosolic oxaloacetate towards malate formation, reducing gluconeogenesis from TCA. In addition DHAP is shifted toward glycerol- 3- phosphate formation and thus reducing gluconeogenesis from glycerol.  The low blood glucose leads to a stress response 9 rapid heart beat, clammy skin), an effort to enhance stimulation of gluconeogenesis combined action of glucagon and epinephrine. Rapid breathing is physiological response to metabolic acidosis. Alcohol Excess and Hypoglycemia 2
  • 75.  Premature babies are more susceptible to hypoglycemia than normal babies because: They have larger brain to body ratio.  Small stores of glycogen.  Limited capacity of live gluconeogenesis because of immaturity of the liver cells and the immaturity of PEPCK.  Limited capacity for ketogenesis. Sudden Infant Death Syndrome (SIDS)
  • 76.  DM is a group of metabolic diseases characterized by hyperglycemia leading to long term complication.  It is common, which affects 1-2 % of populations.  There are two main forms diabetes, 10 % have type I and 90% have type 2.  Type 1 patients are unable to produce insulin and must receive exogenous insulin to survive.  Type 2 patients have at least partially preserved insulin secretion, but often insulin resistant.  Some patients may have no clinical symptoms at all, with diagnosis made exclusively on the basis of laboratory results. Diabetes Mellitus ( DM)
  • 77.
  • 78.  Type one  It is not genetically predetermined.  Increase susceptibility to the diseases is inherited.  Sibling has a 10 % chance of developing diabetes by the age of 40.  Susceptibility is associated with HLA genes ( HLA DR3 and or DR4, DQ W) Genetics of Diabetes
  • 79.  Type two  It is polygenic disorder ( no evidence of immune involvement)  Sibling have 50 % increased risk of developing diabetes.  Genes for majority of cases have yet to be identified.  Many genetic causes which include: Mutations of insulin receptors Deletion of mitochondrial DNA Mutations effect the structure of insulin Genetics of Diabetes
  • 80.  In absence of insulin  Hepatic glucose production accelerate  Peripheral glucose uptake is reduced  Hyperglycemia leads to  Osmotic diuresis  Loss of fluid and electrolytes  Dehydration  Plasma osmolality rises and renal perfusion falls Metabolism in uncontrolled diabetes
  • 81.  In parallel:  Rapid lipolysis occurs  Elevated circulatory FFA  Rising ketogenesis  Rising plasma ketone bodies which produce metabolic acidosis  Vomiting leads to further loss of fluid and electrolytes  Progressive dehydration impairs renal excretion of hydrogen ions and ketones Metabolism in uncontrolled diabetes
  • 82.  Type I diabetes develop in young people, with the peak incidence at approximately 12 years of age.  It is caused by autoimmune destruction of pancreatic B- cells. The precipitating cause is still unclear ( viral infection initiate the chain of autoimmune reaction, alternatively, cytokine response to viral infection, or another insult, could attract monocytes and macrophages that infiltrate and destroy the pancreatic islets).  A proportion of patients have antibodies against B- cell proteins.  Auto- antibodies to insulin are also seen in some individuals. Type I Diabetes
  • 83.  Type 2 diabetes usually develop in patients who are over 40 years old and are typically obese.  The pathogenesis in type 2 diabetes involve the impairment of insulin secretion and insulin resistance.  The response of the diabetic B- cell to the glucose stimulus is suboptimal and there is no first phase of insulin secretion. Type 2 Diabetes
  • 84.  Diabeteic ketoacidosis, a sudden (acute ) metabolic disturbance, is only one part of the diabetic syndrome.  The other is the slow development of changes in small (microangiopathy) and large (macroangiopathy) arteries.  Diabetic complications lead to diabetic kidney failure ( nephropathy), blindness ( retinopathy) and to the impairment of nerve function ( neuropathy).  Peripheral vascular disease is a major cause of foot ulcers and lower limb amputations. Long term complications of Diabetes
  • 85.  Type 1: Daily subcutaneous insulin injections throughout life. Patients in whom blood glucose is difficult to control are treated with several injections per day, or sometimes, with a constant insulin infusion, delivered by a programmable, portable pump. Diet and exercise are also important in the management of diabetes.  Type 2 : Diabetic patients do not usually require insulin treatment because insulin synthesis is at least partly preserved. Instead, the treatment relies on diet and oral hypoglycemic agents. Drugs such as sulfonylurea derivatives stimulate insulin secretion. Another class of compounds ( metformin) reduce hyperglycemia by increasing peripheral glucose uptake. Treatment of Diabetes:
  • 86.  A 15 year old girl is admitted to the Accident and Emergency department. She is confused and her breath smells of acetone. She has dry skin and tongue, which are signs of dehydration. She also takes quick, deep breaths ( hyperventilation). Here RBG is 18.0 mmol/l ( 324 mg/dl) and ketones are present in the urine. Her serum potassium concentration is 3.5 mmol/l ( normal 3.5- 5.0 mmol/l) and her arterial blood pH is 7.2 ( normal 7.37 – 7.44).  Comment: this is a typical presentation of diabetic ketoacidosis. Hyperventilation is a compensatory response to acidosis. This patient needs to be treated as a medical emergency. She will receive an intravenous infusion containing physiologic saline with potassium supplement to replace lost fluid, and an insulin infusion. Typical presentation of diabetic ketoacidosis
  • 87. Address four issues:  Insulin infusion to reverse the metabolic effects of the excess of anti- insulin hormones.  Infusion of fluids to treat dehydration.  Intravenous fluids normally contain potassium supplements to prevent a decrease in plasma potassium ( hypokalemia).  When acidosis is severe, infusion of an alkaline solution ( sodium bicarbonate) may be required. Emergency treatment of diabetic ketoacidosis
  • 88.  Insulin increases potassium uptake by cells. Lack of insulin leads to release of potassium, particularly from skeletal muscle. Since uncontrolled diabetes is accompanied by an osmotic diuresis, the released potassium is excreted through the kidney. Most diabetic patients admitted to hospital with ketoacidosis are potassium depleted. Exogenous insulin given to such patients stimulates the entry of potassium into cells. This further depletes the plasma potassium pool and can lead to very low plasma potassium level ( hypolkalemia). Hypokalemia is dangerous, owing to its effects on cardiac muscle. Thus, except for patients with very high potassium level, potassium supplementation needs to be considered in treatment of diabetic ketoacidosis. Diabetic ketoacidosis and potassium
  • 89.  Maintaining near normal blood glucose levels prevents the development of late complications of diabetes. A recently completed landmark clinical study, the Diabetes Control Complications trial , has shown that the development of late complications of diabetes in type I diabetes is related to long term glycemia. This study has also shown that in patients who have complications, good control of glycemic delays further development of retinopathy, nephropathy and neuropathy. Similar results were obtained for type 2 diabetic patients during the UK Prospective Diabetes Study completed in 1998. Thus the aim of treatment of diabetes should be the achievement of blood levels as close to normal as possible, without precipitating hypoglycemia. The importance of good glycemic control
  • 90.  The entry of glucose into brain, peripheral nerve tissue, kidney, intestine, lens and RBC does not depend on insulin action.  During hyperglycemia, the intracellular level of glucose in these cells is high, which promotes the non- enzymatic attachment of glucose to protein molecules.  Glycation involves glucose and alpha- amino terminal amino acid and ε- amino groups of lysine residues.  Hemoglobin, albumin and collagen become glycated which effects their function.  For instance, glycation of apolipoprotein B slows down the rate of receptor dependent metabolism of LDL. Protein modification by glucose
  • 91.  The measurement of blood glucose remains the most important laboratory test in diabetes.  As erythrocytes age, there is gradual conversion of a fraction of native hemoglobin ( HbA) to its glycated form, HbA1C, so that an older red cell, a greater fraction of HbA exist as HbA1C.  HbA1C concentration in blood reflects the time – averaged level of glycemia over the 3-6 weeks preceding the measurement.  The normal concentration of HbA1C is 4-6% of HbA. Levels below 7% indicate acceptable control of diabetes. Higher levels suggest poor control. Glycated Hemoglobin (HbA1C)
  • 92.  A 15 year old insulin dependent boy visited a Diabetic Clinic for a check up. He tells the doctor that he complies with all the dietary advice and never misses insulin. Indeed, his random blood glucose is 6 mmol/l ( 108 mg/dl), but his HbA1C concentration is 11 % ( normal 4- 6 %). He has no glucosuria or ketones in his urine.  Comment: blood and urine glucose results indicate good control of this boy’s diabetes at the time of measurements, whereas the HbA1C level suggests poor control over the last 3-6 weeks. The probability is that he only complies with treatment days before he was due to come to the clinic. This is not uncommon in adolescent, who find it hard to accept the necessity to adjust to their lifestyle to the requirement of diabetes HbA1C identifies patients who do not comply with treatment
  • 93.  Insulin consists of two chains linked by two disulphide bonds. During insulin synthesis a signal sequence is cleaved from pre proinsulin by a peptidase, yielding proinsulin.  Proinsulin consists of the insulin sequence interspersed by a connecting peptide ( C – peptide). At the final stage of insulin synthesis, proinsulin is split into insulin and C- peptide released.  C- peptide is released in an amount equimolar to insulin. This is used to asses beta cell function in patients treated with exogenous insulin.  In these patients, endogenous insulin cannot be measured directly, because the exogenous insulin would interfere in the assay. In such circumstances, C- peptide measurement provides an assessment of beta cell function. Insulin and C- peptide
  • 94.  Glucose can be reduced to sorbitol by the action of aldose reductase. Sorbitol is further oxidized by sorbitol dehydrogenase to fructose. Since aldose reductase has a high Km for glucose, the pathway is not very active at normal glucose level.  In hyperglycemia, however, glucose levels in insulin independent tissues, such as the RBC, nerve and lens, increase and consequently there is an increase in the activity of the polyol pathway with depletion of NADPH.  Like glucose, sorbitol exerts an osmotic effect. This is thought to play a role in the development of diabetic cataracts.  In addition, the high level of sorbitol decreases cellular uptake of another alcohol, myoinositol, which in turn causes a decrease in the activity of membrane Na+/ K+ ATPase. This in turn effects nerve function and, along with hypoxia and reduced nerve blood, contributes to the development of diabetic neuropathy. Drugs inhibiting aldose reductase improve nerve function in diabetes. The Polyol Pathway
  • 95.  An apparently normal baby began to vomit and develop diarrhea after breast feeding. These problems, together with dehydration continued for several days, when the baby began to refuse food and developed jaundice, indicative of liver damage, followed by hepatomegaly and then lens opacification ( cataracts). Measurements of glucose in the blood and urine by specific enzymatic technique indicated that levels of glucose were low, consistent with the failure to absorb foods. However glucose measured by a test that determined total reducing sugar was eventually identified as galactose, indicating an abnormality in galactose mechanism known as galactosemia. This finding was consistent with the observation that, when milk was removed from the diet and replaced with an infant formula containing sucrose rather than lactose, the vomiting and diarrhea stopped, and hepatic function was gradually restored. Galactosemia
  • 96.  Comment: the accumulation of galactose in the blood is most often a result of deficiency of Gal-1- P uridyl transferase in liver tissues. Accumulation of the latter interferes with phosphate and glucose metabolism, leading to widespread tissue damage, organ failure, and mental retardation. In addition, accumulation of galactose in tissues results in galactose conversion via polyol pathway to galactitol, and the accumulation of galactitol in the lens results in osmotic stress and formation of cataracts. A milder form of galctosemia is caused by galactokinase deficiency. Galactosemia
  • 97.  A baby, born of poorly controlled, chronically hyperglycemic, diabetic mother was large and chubby at birth ( 5kg.), but appeared otherwise normal. He declined rapidly, however and, within 1 hour showed all of the symptoms of hypoglycemia, similar to the previously described case of baby girl born of a malnourished mother. The difference, in this case, was that the boy was thin, rather than heavy.  Comment: This child has experienced a chronically hyperglycemic environment during uterine development. He adapted by increasing insulin, which has a GH like activity, resulting in macrosomia. At birth, when placental delivery of glucose ceases, he has a normal blood glucose level. However his high blood insulin promotes glucose uptake into muscles and adipose tissue. The resultant insulin induced hypoglycemia leads to stress response, which was corrected by glucose infusion. His ample body mass will provide good blood supply from muscle proteins when gluconeogenesis is activated at 1-2 days post partum. Large child born of a diabetic mother
  • 98.  An autosomal recessive condition, due to deficiency of fructose – 1- phosphate aldolase. The defect causes:  Intracellular accumulation of fructose -1- phosphate.  Inhibition of fructokinase.  Increased blood level of fructose.  Inhibition of glycogen phosphorylase due to depletion of Pi.  Profound hypoglycemia. Fructose intolerance
  • 99.  A baby girl is irritable, sweaty and lethargic and demands food frequently. Physical examination indicates an extended abdomen, resulting from enlarged liver. Blood glucose, after a meal, was 3.5 mmol/l (70 mg/ dl). After 4 h, the child was exhibiting irritability and sweating, her heart rate was increased and blood glucose had declined to 2 mmol/l ( 40 mg/dl). These symptoms were corrected by feeding. A liver biopsy showed massive deposition of glycogen in the liver cytosol.  Comments: She has deficiency in glycogen mobilization. Because of the severity of hypglycemia, the most likely mutation is in hepatic glucose- 6- phosphatase, which is required for glucose production by both gluconeogenesis and glycogenolysis. Von Gierk’s Disease
  • 100.  A genetic recessive disorder, due to absence of lysosomal glucosidase which results in  Generalized (liver, heart and muscle)  Excessive glycogen concentrations found in abnormal vacuoles in the cytosol.  Normal blood sugar  Severe cardiomegaly  Early death usually occurs  Normal glycogen structure Pompe’s disease
  • 101.  A 30 year old man complains of chronic arm and leg muscle pain and cramps during exercise. The pain generally disappeared after about 15- 30 minutes, then he could continue his exercise without discomfort. This blood glucose level was normal during exercise, but his serum creatine kinase (MM) was elevated. Blood glucose declined slightly during exercise, but unexpectedly blood lactate also declined, rather than increased, even when he was experiencing muscle cramp. A biopsy indicated an unusually high level of glycogen in muscle.  Comment: this patient suffers from rare deficiency of muscle phosphorylase activity. Since the patient did not excrete lactate into the blood after intense exercise, suggests a failure to mobilize muscle glycogen. His recovery after half an hour results from epinephrine mediated response that provides both glucose and fatty acids from blood overcoming deficiency in muscle glycogenolysis. McArdle’s disease
  • 102.
  • 103.
  • 104.  Just prior to planned departure to the tropics, a patient visits his physician, complaining of weakness and noting that his urine had recently become unexplainably dark. Physical examination revealed slightly jaundiced ( yellow, icteric ) sclera. Laboratory tests indicated a low hematocrit, a high reticulocyte count, and significantly increased blood level of bilirubin. The patient has been quite healthy during a previous visit a month ago when he received immunizations and prescriptions for drugs related to his travel plan Glucose 6 phosphate dehydrogenase deficiency 1
  • 105.  Comments: A number of drugs, particularly primaquine and related antimalarials, undergo reactions in the cell, producing large quantities of superoxide and H2O2. Superoxide dismutase converts superoxide into H2O2, which is inactivated by glutathione peroxidase using NADPH. Some persons have genetic defect in G6PD, typically yielding an unstable enzyme that has a shorter life in the RBC. Therefore insufficient production of NADPH under stress, the cell ability to recycle GSSG to GSH is impaired and drug induced oxidative stress leads to lysis of RBC’s and hemolytic anemia. If the hemolysis is severe enough Hb spills over into the urine, resulting in hematuria and dark colored urine. Older cells, which can’t synthesize and replace their enzyme are therefore particularly affected. Genetically the deficiency is X- linked. Favism is associated with G6PD deficiency. Glucose 6 phosphate dehydrogenase deficiency 2

Editor's Notes

  1. There are four additional “bypass” enzymes required in addition to all the same “reversible” enzymes of glycolysis.
  2. This slide outlines the net reaction (What?) of gluconeogenesis, which is an anabolic pathway.